Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Gilead Sciences
GILD
|
+$238M |
| 2 |
Johnson & Johnson
JNJ
|
+$224M |
| 3 |
MON
Monsanto Co
MON
|
+$219M |
| 4 |
AET
Aetna Inc
AET
|
+$215M |
| 5 |
Broadcom
AVGO
|
+$179M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
+$242M |
| 2 |
Microsoft
MSFT
|
+$232M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$205M |
| 4 |
Home Depot
HD
|
+$188M |
| 5 |
Nike
NKE
|
+$187M |
Sector Composition
| 1 | Financials | 14.12% |
| 2 | Technology | 13.1% |
| 3 | Healthcare | 12.08% |
| 4 | Industrials | 11% |
| 5 | Consumer Staples | 8.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2026
EPAM Systems
EPAM
$8.69B
| $2.86M | ﹤0.01% |
+44,400
| New | +$2.86M |
|
2027
CrossAmerica Partners
CAPL
$774M
| $2.86M | ﹤0.01% |
113,337
-9,663
| -8% | -$243K |
|
2028
Church & Dwight Co
CHD
$22.6B
| $2.85M | ﹤0.01% |
64,400
-356,900
| -85% | -$15.8M |
|
2029
Golden Entertainment
GDEN
$638M
| $2.85M | ﹤0.01% |
234,950
-22,050
| -9% | -$267K |
|
2030
Baxter International
BAX
$12.3B
| $2.84M | ﹤0.01% |
64,100
-93,900
| -59% | -$4.16M |
|
2031
H&R Block
HRB
$6.86B
| $2.83M | ﹤0.01% |
123,088
-693,312
| -85% | -$15.9M |
|
2032
Nice
NICE
$8.82B
| $2.83M | ﹤0.01% |
41,144
-34,500
| -46% | -$2.37M |
|
|
NOA
2033
North American Construction
NOA
$399M
| $2.82M | ﹤0.01% |
733,260
+144,217
| +24% | +$555K |
|
2034
Synchronoss Technologies
SNCR
$66.9M
| $2.82M | ﹤0.01% |
8,189
+5,933
| +263% | +$2.05M |
|
2035
First Financial Bankshares
FFIN
$5.12B
| $2.82M | ﹤0.01% |
124,800
-172,800
| -58% | -$3.9M |
|
|
EVA
2036
DELISTED
Enviva Inc.
EVA
| $2.82M | ﹤0.01% |
105,200
-46,200
| -31% | -$1.24M |
|
2037
Diana Shipping
DSX
$225M
| $2.82M | ﹤0.01% |
1,333,778
+113,711
| +9% | +$240K |
|
2038
Adverum Biotechnologies
ADVM
$63.4M
| $2.81M | ﹤0.01% |
96,970
-3,470
| -3% | -$101K |
|
|
CBPX
2039
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
| $2.81M | ﹤0.01% |
121,700
-97,800
| -45% | -$2.26M |
|
2040
Cato Corp
CATO
$91.1M
| $2.8M | ﹤0.01% |
93,200
-98,750
| -51% | -$2.97M |
|
|
NVLN
2041
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
| $2.8M | ﹤0.01% |
+332,870
| New | +$2.8M |
|
2042
Acme United Corp
ACU
$156M
| $2.8M | ﹤0.01% |
109,600
+2,000
| +2% | +$51.1K |
|
|
EQY
2043
DELISTED
Equity One
EQY
| $2.78M | ﹤0.01% |
+90,500
| New | +$2.78M |
|
|
CHCT
2044
Community Healthcare Trust
CHCT
$445M
| $2.76M | ﹤0.01% |
120,000
-31,200
| -21% | -$719K |
|
|
EFC
2045
Ellington Financial
EFC
$1.34B
| $2.76M | ﹤0.01% |
177,962
+33,613
| +23% | +$522K |
|
2046
Triumph Financial, Inc.
TFIN
$1.4B
| $2.76M | ﹤0.01% |
105,400
+59,100
| +128% | +$1.55M |
|
2047
IRIDEX
IRIX
$22.4M
| $2.75M | ﹤0.01% |
195,900
-14,600
| -7% | -$205K |
|
|
OXFD
2048
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $2.75M | ﹤0.01% |
183,700
-15,500
| -8% | -$232K |
|
2049
Ryman Hospitality Properties
RHP
$6.31B
| $2.74M | ﹤0.01% |
43,541
+13,041
| +43% | +$822K |
|
|
GUID
2050
DELISTED
Guidance Software, Inc.
GUID
| $2.73M | ﹤0.01% |
385,700
+14,400
| +4% | +$102K |
|